Broad COVID-19 Vaccinations for Those 5-11 Years Old

I’m writing this blog in very early 2022, a year that looks to be the 3rd most turbulent year in American history. In 2021, our FDA approved an experimental vaccine for broad use in children 5 to 11 years old. There are two very important aspects to this blog that I need to make clear; First science always calls for the benefits of any medical intervention to outweigh any risks inherent to that intervention. Let’s study that.

There are approximately 30,000,000 children in America between 5 and 11 years old. According to the Center for Disease Control (CDC) From October 3, 2020 to Oct 4, 2021 and within that age group, 969 died in accidents, 525 died of cancer and 84 died of the flu and/or pneumonia. During that same time frame, 66 children died of COVID-19. Therefore, children between the ages of 5 and 11 have a 0.0000022% risk of dying from the COVID-19 virus. Given these stats, why are we not mandating the flu shot to this age group since 0.0000028% are dying of complications from the flu? Yet, for many children, the COVID-19 is becoming mandated. It is too early yet to determine ADE’s (Adverse Drug Events) to the COVID-19 vaccine within this age group, but that absolutely must be considered as that one factor either indicates the safety of this vaccine. If no ADES’s are witnessed, then the benefit would outweigh the risks. Conversely, if the vaccine itself induces illnesses and deaths, this would indicate that the risks outweigh the benefits.  Every parent needs to ask their own doctor about this benefit to risk ratio, because it matters.  But, please get answers that you understand.

Second, approval of the experimental COVID0-19 vaccine for children was done by the FDA. The FDA has a very serious conflict of interest which few people know about, but we all need to know about it to make an informed decision as to whether or not to recommend the vaccine for our children.  According to FDA.gov, “Human Drugs regulatory activities account for 33 percent of FDA’s budget”. Further, 65 percent of these activities are paid for by industry user fees. Given their $6,100,000,000 budget in 2021, the very industry that makes COVID-19 drugs and vaccinations will pay about $910,000,000 this year alone directly to the FDA as “user fees.”

In my opinion, this is analogous to the foxes paying the hens “user fees” to enter the hen houses each evening to make certain that the hens are safe. This relationship should be factored in when deciding on the benefits vs. the risks of any medication, let alone an experimental vaccination for a disease that claims 66 lives within this age group annually.

Related Articles

Are you considering a COVID-19 vaccination for your children?